等待開盤 10-27 09:30:00 美东时间
+0.098
+6.86%
Nanobiotix announced the completion of transferring sponsorship and operational control of the NANORAY-312 clinical trial for JNJ-1900 (NBTXR3) to Johnson & Johnson. Interim data analysis is expected in 1H2027 after recruitment and requisite events. Nanobiotix will continue to provide updates on its sponsored studies and collaborations. JNJ-1900, a novel oncology product, is activated by radiotherapy and has shown potential in treating solid tumo...
10-24 06:00
NANO Nuclear Energy收购Global First Power(加拿大),获得了在Ontario建造KRONOS MMR™示范项目的加拿大核安全委员会许可申请,加强其在北美微型核反应堆开发的领先地位。NANO正在Canada和美国同步推进许可和建设项目,计划通过收购后的监管和施工进展加速商业化部署。
10-22 12:00
New York, N.Y., Oct. 20, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) has been included in Morgan Stanley’s National Security Index (MSXXNSEC), recognizing its advanced nuclear microreactor technologies aimed at strengthening U.S. energy sovereignty and national security. NANO Nuclear’s inclusion highlights its role in developing critical energy technologies, such as its KRONOS MMR™ Micro Modular Reactor Energy System. The comp...
10-20 12:00
NANO Nuclear Energy Inc. (NASDAQ: NNE), an advanced nuclear energy company, announced its participation in upcoming investor events, including the Spartan Capital Investor Conference 2025, Bank of America Clean Tech Symposium 2025, Benchmark’s 14th Annual Discovery One-on-One Conference, B. Riley Securities’ Convergence Conference, and Northland Capital Markets Growth Conference. The company develops clean energy solutions across five business li...
10-16 12:30
NANO Nuclear Energy Inc. announced a milestone event on October 24, 2025, at the University of Illinois Urbana-Champaign to showcase progress on its KRONOS MMR™ microreactor prototype. The event will highlight site characterization and drilling activities by AECOM, serving as a关键 step toward submitting a construction permit application in early 2026. The KRONOS MMR™, a high-temperature gas-cooled microreactor, aims to provide carbon-free power fo...
10-14 12:00
NANO Nuclear Energy Inc. has announced a $400 million oversubscribed private placement of common stock under Nasdaq rules. The offering, led by institutional investors, is expected to close by October 10, 2025. Proceeds will support the KRONOS MMR Energy System development, other microreactor projects, strategic acquisitions, and general corporate purposes. The company's cash position is expected to reach approximately $600 million post-closing.
10-08 03:36
NANO Nuclear Energy Inc. announced it will establish a manufacturing and research & development facility in Illinois with a $12 million investment, supported by a $6.8 million incentive award from the REV Illinois program. The facility will create 50 new jobs and focus on advancing nuclear energy solutions, including the KRONOS MMR™ Microreactor Energy System in collaboration with the University of Illinois Urbana-Champaign. Governor JB Pritzker ...
10-07 13:30
Nanoviricides (AMEX:NNVC) reported quarterly losses of $(0.13) per share. This is a 31.58 percent increase over losses of $(0.19) per share from the same period last year.
09-30 05:55
Updated Phase 1 trial data for NBTXR3 combined with anti-PD-1 in R/M-HNSCC showed promising results, with a 63% DCR and 37% ORR in anti-PD-1 naive patients, and 74% DCR and 32% ORR in resistant patients. Median OS was 15.5 months and 11.4 months, respectively. The treatment remained well-tolerated with feasible injection rates, and safety profiles were favorable. These findings suggest potential for overcoming anti-PD-1 resistance, warranting fur...
09-29 22:30
NANO Nuclear Energy Inc. has been included in the S&P Global Broad Market Index (BMI), S&P Total Market Index (TMI), and SPX Completion Index, enhancing its visibility among global institutional investors. The BMI covers 48 countries and over 99% of global market capitalization, while the TMI and Completion Index expand its presence in the U.S. equity market. NANO Nuclear, a leader in advanced nuclear energy, develops clean energy solutions inclu...
09-25 12:30